Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Toss

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 16, 2023
Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significanceShorouk Makhlouf, Cecily Quinn, Michael Toss, et al.
Cancers|June 19, 2024
Tripartite Motif-Containing 2, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Triple-Negative Breast Cancer Treated with ChemotherapyBrendah K Masisi, Rokaya El Ansari, Lutfi Alfarsi, et al.
Histopathology|June 13, 2024
Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation studyAyat G Lashen, Michael Toss, Islam Miligy, et al.
Cancers|August 27, 2021
The Biological and Clinical Significance of Glutaminase in Luminal Breast CancerBrendah K Masisi, Rokaya El Ansari, Lutfi Alfarsi, et al.
Histopathology|June 28, 2018
Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significanceMaryam Althobiti, Mohammed A Aleskandarany, Chitra Joseph, et al.
Pathology|July 6, 2024
The characteristics and prognostic significance of histone H1 expression in breast cancerAyat G Lashen, Nabeelah Almalki, Michael Toss, et al.
Neoplasia (New York, N.Y.)|December 22, 2023
Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancersAyat Lashen, Abdulbaqi Al-Kawaz, Jennie N Jeyapalan, et al.
NPJ Precision Oncology|November 15, 2023
AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancerNoorul Wahab, Michael Toss, Islam M Miligy, et al.
The Journal of Pathology. Clinical Research|October 24, 2023
AI-based intra-tumor heterogeneity score of Ki67 expression as a prognostic marker for early-stage ER+/HER2- breast cancerWenqi Lu, Ayat G Lashen, Noorul Wahab, et al.
British Journal of Cancer|September 30, 2023
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligenceShorouk Makhlouf, Noorul Wahab, Michael Toss, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|December 16, 2023
Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significanceShorouk Makhlouf, Cecily Quinn, Michael Toss, et al.
Cancers|June 19, 2024
Tripartite Motif-Containing 2, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Triple-Negative Breast Cancer Treated with ChemotherapyBrendah K Masisi, Rokaya El Ansari, Lutfi Alfarsi, et al.
Histopathology|June 13, 2024
Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation studyAyat G Lashen, Michael Toss, Islam Miligy, et al.
Cancers|August 27, 2021
The Biological and Clinical Significance of Glutaminase in Luminal Breast CancerBrendah K Masisi, Rokaya El Ansari, Lutfi Alfarsi, et al.
Histopathology|June 28, 2018
Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significanceMaryam Althobiti, Mohammed A Aleskandarany, Chitra Joseph, et al.
Pathology|July 6, 2024
The characteristics and prognostic significance of histone H1 expression in breast cancerAyat G Lashen, Nabeelah Almalki, Michael Toss, et al.
Neoplasia (New York, N.Y.)|December 22, 2023
Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancersAyat Lashen, Abdulbaqi Al-Kawaz, Jennie N Jeyapalan, et al.
NPJ Precision Oncology|November 15, 2023
AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancerNoorul Wahab, Michael Toss, Islam M Miligy, et al.
The Journal of Pathology. Clinical Research|October 24, 2023
AI-based intra-tumor heterogeneity score of Ki67 expression as a prognostic marker for early-stage ER+/HER2- breast cancerWenqi Lu, Ayat G Lashen, Noorul Wahab, et al.
British Journal of Cancer|September 30, 2023
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligenceShorouk Makhlouf, Noorul Wahab, Michael Toss, et al.
Pageof 3